Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes
ABSTRACT Apolipoprotein L1 (APOL1) risk alleles in donor kidneys associate with graft loss but whether recipient risk allele expression impacts kidney transplant outcomes is unclear. To test whether recipient APOL1 allelic variants independently correlate with transplant outcomes, we analyzed genome-wide SNP genotyping data of donors and recipients from two kidney transplant cohorts, Genomics of Chronic Allograft Rejection (GOCAR) and Clinical Trials in Organ Transplantation 1/17 (CTOT1/17). We estimated genetic ancestry (quantified as proportion of African ancestry or pAFR) by ADMIXTURE and correlated APOL1 genotypes and pAFR with outcomes. In the GOCAR discovery set, we observed that the number of recipient APOL1 G1/G2 alleles (R-nAPOL1) associated with increased risk of death-censored allograft loss (DCAL), independent of genetic ancestry (HR = 2.14; P = 0.006), and within the subgroup of African American and Hispanic (AA/H) recipients (HR = 2.36; P = 0.003). R-nAPOL1 also associated with increased risk of any T cell-mediated rejection (TCMR) event. Analysis of the CTOT cohort validated these associations. Ex vivo studies of peripheral blood mononuclear cells revealed unanticipated high APOL1 expression in activated CD4+/CD8+ T cells and natural killer cells. We detected enriched immune response gene pathways in G1/G2 allele carriers vs. non-carriers among patients on the kidney waitlist and healthy controls. Together our findings highlight a previously unrecognized contribution of recipient APOL1 risk alleles to renal allograft outcomes. This immunomodulatory role has broader implications for immune mediated injury to native kidneys..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
bioRxiv.org - (2021) vom: 15. Dez. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhang, Zhongyang [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1101/2021.05.07.21256570 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI020512597 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI020512597 | ||
| 003 | DE-627 | ||
| 005 | 20230429095049.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210510s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2021.05.07.21256570 |2 doi | |
| 035 | |a (DE-627)XBI020512597 | ||
| 035 | |a (biorXiv)10.1101/2021.05.07.21256570 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Zhang, Zhongyang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Apolipoprotein L1 (APOL1) risk alleles in donor kidneys associate with graft loss but whether recipient risk allele expression impacts kidney transplant outcomes is unclear. To test whether recipient APOL1 allelic variants independently correlate with transplant outcomes, we analyzed genome-wide SNP genotyping data of donors and recipients from two kidney transplant cohorts, Genomics of Chronic Allograft Rejection (GOCAR) and Clinical Trials in Organ Transplantation 1/17 (CTOT1/17). We estimated genetic ancestry (quantified as proportion of African ancestry or pAFR) by ADMIXTURE and correlated APOL1 genotypes and pAFR with outcomes. In the GOCAR discovery set, we observed that the number of recipient APOL1 G1/G2 alleles (R-nAPOL1) associated with increased risk of death-censored allograft loss (DCAL), independent of genetic ancestry (HR = 2.14; P = 0.006), and within the subgroup of African American and Hispanic (AA/H) recipients (HR = 2.36; P = 0.003). R-nAPOL1 also associated with increased risk of any T cell-mediated rejection (TCMR) event. Analysis of the CTOT cohort validated these associations. Ex vivo studies of peripheral blood mononuclear cells revealed unanticipated high APOL1 expression in activated CD4+/CD8+ T cells and natural killer cells. We detected enriched immune response gene pathways in G1/G2 allele carriers vs. non-carriers among patients on the kidney waitlist and healthy controls. Together our findings highlight a previously unrecognized contribution of recipient APOL1 risk alleles to renal allograft outcomes. This immunomodulatory role has broader implications for immune mediated injury to native kidneys. | ||
| 700 | 1 | |a Sun, Zeguo |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Qisheng |e verfasserin |4 aut | |
| 700 | 1 | |a Banu, Khadija |e verfasserin |4 aut | |
| 700 | 1 | |a Chauhan, Kinsuk |e verfasserin |4 aut | |
| 700 | 1 | |a Planoutene, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a Wei, Chengguo |e verfasserin |4 aut | |
| 700 | 1 | |a Salem, Fadi |e verfasserin |4 aut | |
| 700 | 1 | |a Yi, Zhengzi |e verfasserin |4 aut | |
| 700 | 1 | |a Fu, Jia |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Ruijie |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Haoxiang |e verfasserin |4 aut | |
| 700 | 1 | |a Hao, Ke |e verfasserin |4 aut | |
| 700 | 1 | |a O’Connell, Philip |e verfasserin |4 aut | |
| 700 | 1 | |a Ishibe, Shuta |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Weijia |e verfasserin |4 aut | |
| 700 | 1 | |a Coca, Steven G. |e verfasserin |4 aut | |
| 700 | 1 | |a Gibson, Ian W. |e verfasserin |4 aut | |
| 700 | 1 | |a Colvin, Robert B. |e verfasserin |4 aut | |
| 700 | 1 | |a He, John Cijiang |e verfasserin |4 aut | |
| 700 | 1 | |a Heeger, Peter S. |e verfasserin |4 aut | |
| 700 | 1 | |a Murphy, Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a Menon, Madhav C. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2021) vom: 15. Dez. |
| 773 | 1 | 8 | |g year:2021 |g day:15 |g month:12 |
| 856 | 4 | 0 | |u https://doi.org/10.1172/jci146643 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.05.07.21256570 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 15 |c 12 | ||
| 953 | |2 045F |a 570 | ||